NeOnc Technologies Holdings, Inc. Common Stock (NTHI : NASDAQ)
Common Stock
Follow NTHI
NTHI
NeOnc Technologies Holdings, Inc. Common Stock
WealthAwesomePerformance
1 Day
+16.84%
1 Week
+42.35%
1 Month
+57.19%
YTD
-9.15%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$107.90M
52W High
$12.00
52W Low
$2.50
P/E Ratio
-
50 Day MA
$3.33
200 Day MA
$5.34
Beta
-
Dividend Yield
-
Performance history
NTHI returns since 2026
NeOnc Technologies Holdings, Inc. Common Stock has traded since Jun 2026 in our data. Its deepest fall was −54.2% (Aug 2026 to Oct 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*−9.1%
* Partial year (first year of data, or year to date).
$10,000 invested in NTHI
- 2026 (start of our data)$9,085
- All-time high in our data
- $6 on Aug 18, 2026 · now −21.0%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past NTHI? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $3.71 | $4.72 | $3.71 | $4.37 | $4.37 | 390,806 |
| 11/9/2026 | $3.85 | $3.90 | $3.52 | $3.74 | $3.74 | 320,324 |
| 11/6/2026 | $3.25 | $3.52 | $3.13 | $3.49 | $3.49 | 228,026 |
| 11/5/2026 | $3.12 | $3.26 | $2.91 | $3.20 | $3.20 | 151,339 |
| 11/4/2026 | $3.15 | $3.20 | $3.02 | $3.17 | $3.17 | 53,247 |
| 11/3/2026 | $3.04 | $3.33 | $2.99 | $3.07 | $3.07 | 57,203 |
| 11/2/2026 | $3.22 | $3.37 | $3.07 | $3.07 | $3.07 | 93,898 |
| 10/30/2026 | $3.16 | $3.38 | $3.10 | $3.26 | $3.26 | 131,691 |
| 10/29/2026 | $3.00 | $3.19 | $3.00 | $3.12 | $3.12 | 71,652 |
| 10/28/2026 | $2.98 | $3.03 | $2.90 | $3.03 | $3.03 | 65,040 |
Analyst Price Targets
Based on 4 analysts covering NTHI · as of Oct 5, 2026
Wall Street analysts forecast NTHI stock price to rise 289.0% over the next 12 months.
Consensus
Strong Buy4.75 / 5.00
Avg. Target
US$17.00
+289.0% Upside
Current Price
US$4.37
Last close
Analyst Breakdown (4 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NTHI's historical volatility
30-Day Vol
103.4%
Annualized
90-Day Vol
126.8%
Annualized
Trend (90d)
-48.9%
Annualized drift
90d Mean
US$3.67
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$4.12 | US$2.89 – US$5.89 |
| 60 trading days | US$3.89 | US$2.35 – US$6.44 |
| 90 trading days | US$3.67 | US$1.98 – US$6.81 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About NeOnc Technologies Holdings, Inc. Common Stock
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Financials
- Revenue (TTM)
- $39,990
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -1.95
- Book Value
- -0.81
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About NTHI.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SMX | SMX (Security Matters) Public Limited Company Class A Ordinary Shares | $19.25 | +105.88% |
| PEPG | PepGen Ltd | $4.61 | +92.89% |
| TTEC | TTEC Holdings Inc | $2.40 | +72.04% |
| NNOX | Nano X Imaging Ltd | $0.37 | +59.80% |
| TANH | Tantech Holdings Ltd | $30.56 | +58.01% |
| AACG | ATA Creativity Global | $0.89 | +52.14% |
| ESLA | Estrella Immunopharma Inc. | $0.75 | +45.40% |
| MNDO | MIND CTI Ltd | $1.26 | +44.83% |
Free with a Wealth Awesome account
Keep analysing NTHI, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.